诺唯赞跌3.56% 2021年上市超募9亿元

Core Viewpoint - The stock of NuoVasive (688105.SH) closed at 21.96 yuan, reflecting a decline of 3.56% and currently in a state of breaking issue [1] Group 1: Company Overview - NuoVasive was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 15, 2021, with an issuance of 40.01 million shares at a price of 55.00 yuan per share [1] - The total funds raised from the initial public offering (IPO) amounted to 2.201 billion yuan, with a net amount of 2.109 billion yuan after deducting issuance costs [1] - The final net amount raised exceeded the original plan by 907 million yuan [1] Group 2: Fund Allocation - The funds raised are intended for the company's headquarters and new R&D base project, expansion of the marketing network, and to supplement working capital [1] - The total issuance costs for the IPO were 91.38 million yuan, with Huatai United Securities receiving 72.64 million yuan as underwriting and sponsorship fees [1] Group 3: Strategic Investment - Huatai Innovation Investment Co., a subsidiary of the sponsoring institution, participated in the strategic placement of the IPO, acquiring 120.03 thousand shares, which is 3% of the total issuance [1] - The lock-up period for the shares acquired by Huatai Innovation is set for 24 months, starting from the date of listing on the Shanghai Stock Exchange [1]